Status:
COMPLETED
Preoperative Immunonutrition in Laparoscopic Total D2 Gastrectomy
Lead Sponsor:
University of Rome Tor Vergata
Conditions:
Gastric Cancer
Surgery
Eligibility:
All Genders
18+ years
Brief Summary
Immunonutrition (IN) appears to reduce infective complications and in-hospital length of stay (LOS) after gastrointestinal surgery. More specifically, it seems to be beneficial also in gastric cancer ...
Eligibility Criteria
Inclusion
- Age \>18 years
- Primary gastric cancer
- Preoperative staging I-III
- Eligible for laparoscopic D2 total gastrectomy
Exclusion
- Acquired or congenital immunodeficiency
- Malnutrition (MNA-SF score \< 12)
- Preoperative infection
- Previous gastric surgery
- ASA IV
- Emergency setting
- Para-aortic node involvement
- Intraoperative evidence of distant metastasis or peritoneal carcinosis
- Conversion to open surgery
Key Trial Info
Start Date :
January 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2022
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT05259488
Start Date
January 1 2014
End Date
January 1 2022
Last Update
February 28 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.